Email Updates

You are here

Home»Trial Summary Table

Trial Summary Table

Trial Name Phase Start Date Sponsors Countries Population Candidate(s) Status Expected Completion Date
SEARCH Open Label Tuesday, April 30, 2013 University of California, San Francisco, IDRC, Makerere University, Kenya Medical Research Institute, Gilead Sciences, World Bank, NIAID, PEPFAR Kenya, Uganda Women, Men TDF/FTC (Truvada) Ongoing December 2018
Seasonal Use of PrEP in Mozambique Demo Project Monday, February 1, 2016 ICAP, WHO, The Employment Bureau of Africa (TEBA), BMGF Mozambique Women Completed May 2016
Sisters Antiretroviral therapy Programme for Prevention of HIV –an Integrated Response (SAPPH-Ire) Demo Project Tuesday, July 1, 2014 Centre for Sexual Health and HIV/AIDS Research Zimbabwe; University College London; London School of Hygiene and Tropical Medicine ; RTI; DFID; UNFPA Zimbabwe Women TDF/FTC (Truvada) Ongoing October 2016
Slovenian PrEP Demonstration Project Demo Project Tuesday, April 4, 2017 Slovenia MSM Planned
Social Network-Based PrEP Adherence for Transgender Women in Peru (TransPrEP) Demo Project Saturday, April 16, 2016 Peru Women, Men Planned December 2017
Sophocles - P4G Demo Project Monday, December 12, 2016 Medical School of the University of Athens Greece MSM Ongoing December 2017
South Australian PrEP Demonstration Project Demo Project Australia Planned
SPARK Project NYC Demo Project Friday, October 31, 2014 Hunter College; National Institute on Alcohol Abuse and Alcoholism (NIAAA); Gilead Sciences United States of America MSM Ongoing July 2017
SSPN formulations of novel emtricitabine Pre-clinical emtricitabine
Study in Healthy Volunteers of the Safety and Metabolism of Different Doses of the Anti-HIV Drug TMC278LA I Saturday, January 1, 2011 St Stephens Aids Trust United Kingdom Women, Men TMC 278 Completed June 2012

Pages